OncoVista Innovative Therapies, Inc.
OVIT
$0.0001
-$0.0001-50.00%
OTC PK
| 09/30/2015 | 06/30/2015 | 03/31/2015 | 12/31/2014 | 09/30/2014 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 156.20K | 927.20K | 111.90K | 1.46M | 161.60K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 317.40K | 1.09M | 272.80K | 1.73M | 286.80K |
| Operating Income | -317.40K | -1.09M | -272.80K | -1.73M | -286.80K |
| Income Before Tax | -326.10K | -1.10M | -277.50K | -1.57M | 226.80K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -326.10K | -1.10M | -277.50K | -1.57M | 226.80K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -326.10K | -1.10M | -277.50K | -1.57M | 226.80K |
| EBIT | -317.40K | -1.09M | -272.80K | -1.73M | -286.80K |
| EBITDA | -317.30K | -1.09M | -272.70K | -1.73M | -286.80K |
| EPS Basic | -0.01 | -0.05 | -0.01 | -0.07 | 0.01 |
| Normalized Basic EPS | -0.01 | -0.03 | -0.01 | -0.05 | 0.01 |
| EPS Diluted | -0.01 | -0.05 | -0.01 | -0.07 | 0.01 |
| Normalized Diluted EPS | -0.01 | -0.03 | -0.01 | -0.05 | 0.01 |
| Average Basic Shares Outstanding | 23.05M | 22.01M | 22.01M | 21.72M | 21.63M |
| Average Diluted Shares Outstanding | 23.05M | 22.01M | 22.01M | 21.72M | 21.63M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |